The electronic trial master file (eTMF) system market value in 2024 is estimated to be around US$ 1.7 billion, as per a recent report. Clinical trial conduct has increased, and eTMF software developers are supporting this trend by offering scalable and globally accessible eTMF hosting.
The adoption rate of eTMF in clinical trials is predicted to evolve at an impressive CAGR of 12.9% over the next ten years. The report further reveals the electronic trial master file (eTMF) system industry to reach a value of nearly US$ 5.8 billion by 2034 end.
Electronic Trial Master File (eTMF) System Market Trends & Analysis
| Report Attribute | Details |
|---|---|
| Market Revenue (2024) | US$ 1.7 billion |
| Market Anticipated Forecast Value (2034) | US$ 5.8 billion |
| Market Projected Growth Rate (2024 to 2034) | 12.9% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
According to the earlier market survey reports, the electronic trial master file (eTMF) system adoption in 2019 accrued revenue of around only US$ 0.9 billion in 2019. However, in the following years, the worldwide demand for eTMF validation and verification solutions skyrocketed, driving the overall market at an impressive 14.9% CAGR.
As clinical trials became more widespread, effective handling of clinical trial file management across many geographic locations became necessary during the pandemic years. By following this robust growth rate for the next five years, the total valuation of the market was figured out to have reached US$ 1.5 billion by 2023 end.
| Attributes | Details |
|---|---|
| Market Size (2019) | US$ 0.9 billion |
| Total Market Size (2023) | US$ 1.5 billion |
| Overall Market Growth (CAGR 2019 to 2023) | 14.9% |
The use of electronic trial file implementation is being propelled by digital transformation in clinical trials or preclinical research domain. Market players are expected to take more advantage of this trend to grow their business by providing cloud-based document management solutions that support further digitalization of operations.
The flexibility and responsiveness of clinical trial administration have improved these days with the development of modern TMF reference models with capabilities for instantaneous data retrieval and reporting. So, a greater focus on quality management and data compliance to ensure accuracy in clinical trials is expected to increase the eTMF integration with EDC systems and propel the market to new heights.
Principal Consultant
The table below represents the average pace of growth that the electronic trial master file (eTMF) system solution providers can expect to operate in some of the top-performing countries. Another table below predicts the total industry size in such countries by 2034 end, in terms of value, based on the present market expanse and forecasted growth rates.
| Regional Market Comparison | CAGR (2024 to 2034) |
|---|---|
| United States | 13% |
| Japan | 14.4% |
| United Kingdom | 13.8% |
| South Korea | 15.2% |
| China | 13.3% |
The United States currently dominates the electronic trial master file (eTMF) system market owing to the presence of many leading eTMF system vendors. As per the analysis report, the total demand for electronic trial master file (eTMF) systems in the United States is expected to increase at a rate of 13% over the next ten years.
The regional market has strengthened over the years by improving trial management efficiency, particularly through the integration of eTMF systems and CTMS. An ecosystem for clinical trials that is more coherent and effective is anticipated to create more opportunities for the United States market players in the coming days.
China currently accounts for nearly 40 to 50% of the total demand for electronic trial master file SOPs in Asia. As per the market forecasts, the China electronic trial master file system market is likely to witness a year-on-year growth rate of 13.3% through the forecast years.
The adoption of electronic trial master file (eTMF) systems in China increased as it gradually became critical to guarantee the security and integrity of clinical trial data. Moreover, the greater emphasis of the pharmaceutical companies operating in the country on expanding their market globally is expected to boost further the need for the best eTMF systems for pharma companies.
| Regional Market Size | Market Size by 2034 (by Value) |
|---|---|
| United States | US$ 1 billion |
| Japan | US$ 621 million |
| United Kingdom | US$ 230 million |
| South Korea | US$ 351 million |
| China | US$ 917.9 million |
Based on different components constituting the present market of electronic trial master file (eTMF) systems, the services segment currently dominates over the software segment. As per the market estimate report, the demand for eTMF training and support services is forecast to increase at a rate of 12.7% over the next ten years.
| Attributes | Details |
|---|---|
| Top Product Type | Services |
| CAGR from 2024 to 2034 | 12.7% |
| CAGR from 2019 to 2023 | 14.7% |
Among the different end users of trial documentation systems, pharmaceutical companies and biotechnology companies create more than 50% of the demand together. As per the market analysis, this segment is likely to expand further with an annual increment rate of 12.4% between 2024 and 2034.
| Attributes | Details |
|---|---|
| Top End User | Pharmaceutical and Biotechnology Companies |
| CAGR from 2024 to 2034 | 12.4% |
| CAGR from 2019 to 2023 | 14.6% |
The higher requirement for real-time access to trial data at pharmaceutical industries and biotechnology research centers is likely to retain its dominance through the projected years. However, the need for eTMF features and functionalities at contract research organizations (CROs) has soared to enable smooth cooperation across several stakeholders driving collaborative research activities. With the emergence of many new contract research organizations being observed lately, the share of this market segment is expected to rise in the coming days.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Large organizations are primarily drawn to electronic trial master file system developers who include strong data protection measures, encryption, and audit trails in their systems. So, a few leading players with higher credibility currently hold a significant share of the overall market and have rendered a consolidated nature. However, new entrants have recently made considerable advancements by developing clinical trial management software that offers accessible functionality and user-friendly interfaces.
Recent Developments in the Market
In September 2022, Montrium Company introduced two new services, TMF maturity educational training services and expert-led trial master file (TMF) services. These novel service packages have been designed to assist TMF teams and clinical operations at every phase of the clinical trial and its development process.
In June 2022, Anju Software Incorporate introduced a new cloud-based electronic trial master file software application by the name of eTMF Masterwas for its clients. This advanced solution facilitates cooperation between sponsors, CROs, and sites to effectively and securely handle clinical trial information in a cloud setting.
| Attribute | Details |
|---|---|
| Estimated Market Size (2024) | US$ 1.7 billion |
| Projected Market Size (2034) | US$ 5.8 billion |
| Anticipated Growth Rate (2024 to 2034) | 12.9% |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Market Analysis | US$ million or billion for Value and Units for Volume |
| Key Regions Covered | North America, Latin America, Europe, Middle East & Africa (MEA), East Asia, South Asia and Oceania |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Germany, Spain, Italy, France, United Kingdom, Russia, China, India, Australia & New Zealand, GCC Countries, and South Africa |
| Key Segments Covered | By Component or Product Type, By Deployment Type, By Functionality, By End-user Verticals, and By Region |
| Key Companies Profiled |
|
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The electronic trial master file system market is valued at US$ 1.7 billion in 2024.
The electronic trial master file system market is to grow at 12.9% during the forecast period.
The electronic trial master file system market is predicted to be valued at US$ 5.8 billion by 2034.
The United States accounts for nearly 18% of the revenue share of the electronic trial master file system market.
South Korea is to witness a CAGR of 15.3% in sales of the electronic trial master file system through 2034.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023
4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Component
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Component, 2019 to 2023
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Component, 2024 to 2034
5.3.1. Software
5.3.2. Services
5.4. Y-o-Y Growth Trend Analysis By Component, 2019 to 2023
5.5. Absolute $ Opportunity Analysis By Component, 2024 to 2034
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Deployment Mode
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Deployment Mode, 2019 to 2023
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Deployment Mode, 2024 to 2034
6.3.1. Cloud/Web-Based
6.3.2. On-Premise
6.4. Y-o-Y Growth Trend Analysis By Deployment Mode, 2019 to 2023
6.5. Absolute $ Opportunity Analysis By Deployment Mode, 2024 to 2034
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By End User , 2019 to 2023
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User , 2024 to 2034
7.3.1. Pharmaceutical and Biotechnology Companies
7.3.2. Contract Research Organizations
7.3.3. Others
7.4. Y-o-Y Growth Trend Analysis By End User , 2019 to 2023
7.5. Absolute $ Opportunity Analysis By End User , 2024 to 2034
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Component
9.2.3. By Deployment Mode
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Component
9.3.3. By Deployment Mode
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Component
10.2.3. By Deployment Mode
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Component
10.3.3. By Deployment Mode
10.3.4. By End User
10.4. Key Takeaways
11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. UK
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Component
11.2.3. By Deployment Mode
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Component
11.3.3. By Deployment Mode
11.3.4. By End User
11.4. Key Takeaways
12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Component
12.2.3. By Deployment Mode
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Component
12.3.3. By Deployment Mode
12.3.4. By End User
12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Component
13.2.3. By Deployment Mode
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Component
13.3.3. By Deployment Mode
13.3.4. By End User
13.4. Key Takeaways
14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Component
14.2.3. By Deployment Mode
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Component
14.3.3. By Deployment Mode
14.3.4. By End User
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Component
15.2.3. By Deployment Mode
15.2.4. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Component
15.3.3. By Deployment Mode
15.3.4. By End User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2023
16.1.2.1. By Component
16.1.2.2. By Deployment Mode
16.1.2.3. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2023
16.2.2.1. By Component
16.2.2.2. By Deployment Mode
16.2.2.3. By End User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2023
16.3.2.1. By Component
16.3.2.2. By Deployment Mode
16.3.2.3. By End User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2023
16.4.2.1. By Component
16.4.2.2. By Deployment Mode
16.4.2.3. By End User
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2023
16.5.2.1. By Component
16.5.2.2. By Deployment Mode
16.5.2.3. By End User
16.6. UK
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2023
16.6.2.1. By Component
16.6.2.2. By Deployment Mode
16.6.2.3. By End User
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2023
16.7.2.1. By Component
16.7.2.2. By Deployment Mode
16.7.2.3. By End User
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2023
16.8.2.1. By Component
16.8.2.2. By Deployment Mode
16.8.2.3. By End User
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2023
16.9.2.1. By Component
16.9.2.2. By Deployment Mode
16.9.2.3. By End User
16.10. Poland
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2023
16.10.2.1. By Component
16.10.2.2. By Deployment Mode
16.10.2.3. By End User
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2023
16.11.2.1. By Component
16.11.2.2. By Deployment Mode
16.11.2.3. By End User
16.12. Czech Republic
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2023
16.12.2.1. By Component
16.12.2.2. By Deployment Mode
16.12.2.3. By End User
16.13. Romania
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2023
16.13.2.1. By Component
16.13.2.2. By Deployment Mode
16.13.2.3. By End User
16.14. India
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2023
16.14.2.1. By Component
16.14.2.2. By Deployment Mode
16.14.2.3. By End User
16.15. Bangladesh
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2023
16.15.2.1. By Component
16.15.2.2. By Deployment Mode
16.15.2.3. By End User
16.16. Australia
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2023
16.16.2.1. By Component
16.16.2.2. By Deployment Mode
16.16.2.3. By End User
16.17. New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2023
16.17.2.1. By Component
16.17.2.2. By Deployment Mode
16.17.2.3. By End User
16.18. China
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2023
16.18.2.1. By Component
16.18.2.2. By Deployment Mode
16.18.2.3. By End User
16.19. Japan
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2023
16.19.2.1. By Component
16.19.2.2. By Deployment Mode
16.19.2.3. By End User
16.20. South Korea
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2023
16.20.2.1. By Component
16.20.2.2. By Deployment Mode
16.20.2.3. By End User
16.21. GCC Countries
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2023
16.21.2.1. By Component
16.21.2.2. By Deployment Mode
16.21.2.3. By End User
16.22. South Africa
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2023
16.22.2.1. By Component
16.22.2.2. By Deployment Mode
16.22.2.3. By End User
16.23. Israel
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2023
16.23.2.1. By Component
16.23.2.2. By Deployment Mode
16.23.2.3. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Component
17.3.3. By Deployment Mode
17.3.4. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Aurea
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. Covance Inc.
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. Mastercontrol Inc.
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. Oracle
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. Transperfect
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. Veeva Systems
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. ePharmaSolutions
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. Phlex
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. SureClinical Inc
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Technology Insights
View Reports
Electronic Trial Master File (eTMF) System Market
